LONDON, September 21, 2021 (GLOBE NEWSWIRE) – Anaqua, the leading provider of innovation and intellectual property management technologies, today announced that global medical products and technology group ConvaTec will use Anaqua’s AQX platform to more efficiently manage its valuable patent portfolios and brands.
The agreement further strengthens Anaqua’s position in the medical solutions markets, with a growing number of clients from these sectors collaborating with Anaqua as their preferred IP management provider.
With operations in more than 100 countries, ConvaTec is a global medical and technology company focused on therapies for the management of chronic diseases, with leading positions in the advanced wound care, ostomy care, oral health care market. incontinence, intensive care and infusion care. ConvaTec products offer a range of clinical and economic benefits, including prevention of infection, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
Christina Allegrini, Vice President, Deputy General Counsel and Global Head of Intellectual Property at ConvaTec, said, “Our company’s vision is to deliver trusted medical solutions to improve the lives we touch. In this context, one of our key strategic pillars is to innovate in our work and our solutions, supported by increased investments in R&D. Therefore, it is extremely important that we manage our innovation and intellectual property effectively and efficiently – and Anaqua will help us ensure that we do. “
ConvaTec will use Anaqua’s AQX platform for patent and trademark management, annuities and renewals (in collaboration with Anaqua Services) and patent analysis through integration with Anaqua’s AcclaimIP.
Bob Romeo, Anaqua CEO, said: “We are proud to work with and support ConvaTec, a company focused on innovation to better serve people around the world in need of advanced medical care. For our part, we look forward to helping ConvaTec protect its innovation and intellectual property management needs. We are also excited to add another global company to our growing portfolio of clients in the healthcare and life sciences industries. “
Anaqua, Inc. is a leading provider of integrated intellectual property (IP) management technology solutions and services. Anaqua’s AQX platform combines best practice workflows with big data analytics and technology services to create an intelligent environment designed to inform IP strategy, enable IP decision making, and streamline IP operations. Today, nearly half of the top 100 applicants for U.S. patents and global trademarks, as well as a growing number of law firms around the world, use Anaqua’s solutions. Over one million intellectual property executives, lawyers, paralegals, administrators and innovators use the platform for their intellectual property management needs. The company’s global operations are based in Boston, with offices in the United States, Europe and Asia. For more information, please visit anaqua.com, or on LinkedIn.
ConvaTec is a global medical products and technology company focused on therapies for the management of chronic disease, with leading positions in advanced wound care, ostomy care, continence and intensive care, and infusion care. Headquartered in the UK, the company has operations in over 100 countries and has nearly 10,000 employees worldwide. ConvaTec products offer a range of clinical and economic benefits, including prevention of infection, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit convatecgroup.com.